You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 13, October 3, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic

Clinical Trial Registries

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The status of and experiences with clinical trial registration were reviewed by Dr Zarin and colleagues.1 An issue that was not raised in this article was the unforeseen extra work generated for researchers as a result of the success of ClinicalTrials.gov in reaching the general public.

In the 2 years after registering a new investigation with ClinicalTrials.gov, I received hundreds of e-mails from patients and other nonclinicians. Most were interested in enrollment, even though the study had reached its target and was now closed. Some apparently viewed the e-mail link as access to obtain medical advice. A colleague contacted me for preliminary results before the trial was completed. I even received e-mails from persons trying sell me products for my office—ClinicalTrials.gov as a gateway to direct marketing!

It is likely that most researchers would feel obliged to answer such e-mail (except perhaps the spam). It is important . . . [Full Text of this Article]

Jais Oliver Berg, MD
joberg@dadlnet.dk
Department of Plastic Surgery
Odense University Hospital
Odense, Denmark


RELATED LETTERS

Clinical Trial Registries

JAMA. ;298():1514-1514.
FULL TEXT  

Clinical Trial Registries Reply
, , , , and
JAMA. ;298():1515-1515.
FULL TEXT  

RELATED ARTICLE

Issues in the Registration of Clinical Trials
, , , , , and
JAMA. ;297():2112-2120.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.